The Persian Version of the COVID-19 Phobia Scale (Persian-C19P-S) and the Differences in COVID-19-Related Phobic Reactions in Patients with Anxiety Disorders

Ardestani, Seyed Mehdi Samimi; Khosravani, Vahid; Bastan, Farangis Sharifi; Baloğlu, Mustafa

doi:10.1007/s11469-021-00523-0

Cited by 17 publications

(27 citation statements)

References 68 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Understanding the excessive reactions given by individuals to the negative effects and consequences of COVID‐19 has been an integral part of this adaptation study. As the scale has been adapted to seven languages (i.e., English, Persian, Indonesian, Korean, Arabic, Portuguese, and Russian) with ongoing adaptation studies in several more languages (Alnaddaf & Baloğlu, 2021 ; Anggraeni et al, 2021 ; Ardestani et al, 2021 ; Arpaci et al, 2022 ; Baloğlu & Gül, 2021 ; Bilgiç et al, 2021 ; Leite et al, 2021 ). We expected that making this scale available to Japanese population would contribute to research and practice.…”

Section: Discussionmentioning

confidence: 99%

“…The original version of the scale was reported to have adequate psychometric properties; such as internal consistency (Cronbach's alpha [CA] coefficient = 0.926 for the overall scale), adequate model fit (loadings ranging from 0.63 to 0.81), and discriminant validity (Arpaci et al, 2020 ). The scale was translated and adapted to several languages, such as English (Arpaci et al, 2022 ), Persian (Ardestani et al, 2021 ), Indonesian (Anggraeni et al, 2021 ), Korean (Bilgiç et al, 2021 ), Arabic (Alnaddaf & Baloğlu, 2021 ), Portuguese (Leite et al, 2021 ), and Russian (Baloğlu & Gül, 2021 ). Additional adaptations for German, French, and Spanish are being carried out by various researchers.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

The Japanese adaptation and validation of the COVID‐19 Phobia Scale (C19P‐S)

Özdemir

Baloğlu

Şahin

2022

Journal Community Psychology

Self Cite

View full text Add to dashboard Cite

There exists a significant need of screening, measuring, and assessing phobic reactions to the negative effects and consequences of coronavirus disease 2019 (COVID‐19) across the world. For this purpose, the C19P‐S has been developed and adapted to several languages and cultures including Turkish, Russian, Arabic, English, Korean, and soforth. This study aimed to adapt the scale into Japanese. Convenience sampling was used in the recruitment of the participants. The sample involved 310 Japanese‐speaking natives from different prefectures of the country (Mean AGE = 49.97; SD = 13.07). The scale is a self‐report instrument, which includes 20, 5‐point Likert‐type items. The scale assesses the levels of COVID‐19 phobia in four areas: Psychological, Somatic, Economic, and Social. The validity (content, construct, convergent, and discriminant) and reliability (internal consistency) analyses were conducted. Multivariate analysis of variance (MANOVA) was used for group comparisons. MANOVA results show that women scored statistically higher in the psychological area. Furthermore, the participants with a lower educational level scored higher than those with a higher level in the somatic area. Among other scales measuring fear and anxiety, the C19P‐S Japanese (C19P‐SJ) is the first measurement tool specifically designed and adapted for evaluating coronaphobia. It is suggested that the individuals with psychiatric diagnoses be included to measure and support the construct validity of the scale.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

The Japanese adaptation and validation of the COVID‐19 Phobia Scale (C19P‐S)

Özdemir

Baloğlu

Şahin

2022

Journal Community Psychology

Self Cite

View full text Add to dashboard Cite

show abstract

“…In fact, Arpaci and colleagues have developed a measure of COVID-19 phobia based on criteria described in disease classification systems such as DSM-IV (8). In accordance, several studies reported negative consequences of COVID-19 phobia in different parts of the world (6)(7)(8)17). Death due to lack of presenting to the hospital because of fear of contracting COVID-19 is a documented example (17).…”

Section: Introductionmentioning

confidence: 99%

“…However, the general public and vulnerable groups are not exempted from experiencing negative emotional reactions. This is because of numerous distressing features of the pandemic: (1) wide geographical expansion of the disease, (2) announcement of COVID-19 as a global pandemic by the World Health Organization (WHO) entailing confirmed information on human-to-human transmission of the disease, (3) aggressive nature of the disease and rising death rates, (4) lack of diseasespecific treatments, (5) uncertainty concerning the protective effects of evolving vaccines, (6) economic consequences of the outbreak, and (7) terrorizing images and stories of the pandemic communicated by mass media and social media (1,(5)(6)(7)(8)(9)(10).…”

Section: Introductionmentioning

confidence: 99%

COVID-19-Related Psychological Trauma and Psychological Distress Among Community-Dwelling Psychiatric Patients: People Struck by Depression and Sleep Disorders Endure the Greatest Burden

Ali

Alkhamees

Elhay

et al. 2022

Front. Public Health

View full text Add to dashboard Cite

COVID-19 has created a general state of worry and distress, especially among vulnerable groups such as those with psychiatric diagnoses. Worldwide, psychiatric care provision has drastically suffered during the pandemic, with many patients unable to access proper care, which may have implications for increased mental health consequences in patients with psychiatric disorders (e.g., relapse and suicide). This cross-sectional study used structural equation modeling to investigate COVID-19-related trauma and distress among Arab psychiatric population during COVID-19 quarantine. Patients with pre-existing psychiatric disorders (N = 168) completed an online survey that comprised the Depression Anxiety Stress Scale 21 (DASS-21), the Impact of Event Scale-Revised (IES-R), and a questionnaire on COVID-19-related attitudes/perceptions, sources of information, used protective measures, and socio-demographic information. Respondents commonly reported feeling down-hearted/blue, trouble concentrating, along with symptoms of avoidance and rumination related to the pandemic. Patients with depression and sleep disorders expressed higher COVID-19-related trauma than patients with other disorders. Perceived physical health mediated the effect of co-morbid chronic physical disorders on COVID-19 trauma, psychological distress, perceived vulnerability to COVID-19, and perceived likelihood of recovery in case of contracting COVID-19. Perceived physical health and perceived vulnerability to COVID-19 were strong direct predictors of COVID-19-related trauma and psychological distress. Staying at home negatively predicted COVID-19 trauma and exerted an indirect negative effect on psychological distress via COVID-19 trauma. COVID-19 trauma, age, and marital status directly predicted psychological distress, with COVID-19 trauma being the strongest predictor. Educational level, income, having family members working in the medical field, keeping up to date with the news on deaths/infected cases or the development of COVID-19 drugs or vaccines, satisfaction with available information on COVID-19, and using different protective measures were not associated with significant differences in COVID-19 trauma and psychological distress scores. Immuno-psychiatric interventions should be designed to target COVID-19-trauma and distress among younger single patients with perceived poor physical health, especially those diagnosed with depression and sleep disorders.

show abstract

“…In 2019, novel coronavirus (COVID-19) rapidly spread around the world. The disease was highly infectious, fast transmission, high mortality and poor prognosis, affecting human economic, social and health, causing fear, anxiety and avoidance, and emphasizing the fear of patients with mental illness (4). Traditional Chinese medicine plays an important role in the prevention and control of the epidemic, and has unique advantages in the treatment of fear and anxiety, and other emotional diseases (5).…”

Section: Introductionmentioning

confidence: 99%

Network pharmacology study on the mechanism of Qiangzhifang in the treatment of panic disorder

et al. 2021

View full text Add to dashboard Cite

Background: Panic disorder (PD) is a kind of mental illness characterized by the symptom of recurring panic attacks. Qiangzhifang (QZF) is a novel decoction developed by Professor Zhaojun Yan based on a unique system of syndrome differentiation and clinical experience. It has achieved remarkable results after long-term clinical practice, but its mechanism of action is still unclear. This study aims to use network pharmacology and molecular docking to explore the mechanism of QZF in the treatment of PD. Methods: We used the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), a literature search, and Encyclopedia of Traditional Chinese Medicine (ETCM) to find active ingredients and targets of QZF. We searched for PD targets in GeneCards, Online Mendelian Inheritance in Man (OMIM), the Comparative Toxicogenomics Database (CTD), and DrugBank. We established a PD target database, constructed a protein-protein interaction (PPI) network, and performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis in order to screen possible pathways of action and analyze the mechanism.Results: This study identified 84 effective components of QZF, 691 potential targets, 357 PD targets, and 97 intersectional targets. Enrichment analysis using the Database for Annotation, Visualization, and Integrated Discovery (DAVID) showed that QZF was associated with 118 biological processes (BPs), 18 cellular components (CCs), 35 molecular functions (MFs) [false discovery rate (FDR) <0.01], and 62 pathways (FDR <0.01). QZF mainly acts on its targets AKT1, FOS, and APP through active ingredients such as quercetin, β-sitosterol, 4-(4'-hydroxybenzyloxy)benzyl methyl ether, harmine, 1,7-dimethoxyxanthone, and 1-hydroxy-3,7-dimethoxyxanthone to regulate serotonin, gamma-aminobutyric acid (GABA), cyclic adenosine monophosphate (cAMP), and other signal pathways to treat PD.Conclusions: Through network pharmacology and molecular docking technology, we predicted the possible mechanism of QZF in the treatment of PD, revealed the interaction targets and potential value of QZF, and provided a basis for its clinical application.

show abstract

The Persian Version of the COVID-19 Phobia Scale (Persian-C19P-S) and the Differences in COVID-19-Related Phobic Reactions in Patients with Anxiety Disorders

Cited by 17 publications

References 68 publications

The Japanese adaptation and validation of the COVID‐19 Phobia Scale (C19P‐S)

The Japanese adaptation and validation of the COVID‐19 Phobia Scale (C19P‐S)

COVID-19-Related Psychological Trauma and Psychological Distress Among Community-Dwelling Psychiatric Patients: People Struck by Depression and Sleep Disorders Endure the Greatest Burden

Network pharmacology study on the mechanism of Qiangzhifang in the treatment of panic disorder

Contact Info

Product

Resources

About